UB Paderborn / Katalog / Suche / in CDI

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Journal of clinical oncology, 2012-11, Vol.30 (31), p.3792-3799

2012

Volltextzugriff (PDF)

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3197-3204

2013

Volltextzugriff (PDF)

Clinical Impact of a Value-Based Decision: A Surgical Case Study

Journal of the American College of Surgeons, 2013-04, Vol.216 (4), p.800-811

2013

Volltextzugriff (PDF)

Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

International journal of oncology, 2012-11, Vol.41 (5), p.1570-1576

2012

Volltextzugriff (PDF)

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma

Journal of Clinical Immunology, 2006-07, Vol.26 (4), p.331-338

2006

Volltextzugriff (PDF)

Abstract 4224: CD133 knockdown sensitizes melanoma to kinase inhibitors

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4224-4224

2015

Volltextzugriff (PDF)

Abstract 3891: CD133 is associated with resistance of melanoma to multikinase inhibition

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3891-3891

2014

Volltextzugriff (PDF)

Abstract 1097: Immunohistochemical expression of growth factor receptors in different stages of human cutaneous melanoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1097-1097

2011

Volltextzugriff (PDF)

Abstract 3349: Immunoexpression of human melanoma stem markers during progressive stages of the disease

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3349-3349

2010

Volltextzugriff (PDF)

Abstract 1921: Nonadherent human melanoma cell lines from lymph node metastases coexpress B cell markers and melanoma antigens

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1921-1921

2010

Volltextzugriff (PDF)

NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer

Journal of clinical oncology, 2012-06, Vol.30 (18_suppl), p.LBA1000-LBA1000

2012

Volltextzugriff (PDF)

NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC followed by paclitaxel (P) plus gemcitabine (G) with DD AC followed by P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.LBA1000-LBA1000

2012

Volltextzugriff (PDF)

Diminished dose minimally invasive radioguided parathyroidectomy : A case for radioguidance. Discussion

The American surgeon, 2007-07, Vol.73 (7), p.669-673

2007

Volltextzugriff (PDF)

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

Journal of the American College of Surgeons, 2004-09, Vol.199 (3), p.81-81

2004

Volltextzugriff (PDF)

The Effect of Sequential Administration of Human Granulocyte-Macrophage Colony Stimulation Factor (GM-CSF) and Interleukin-2 (IL-2): A New Postoperative Adjuvant Therapy in High-Risk Melanoma Patients

Southern medical journal (Birmingham, Ala.), 2003-11, Vol.96 (Supplement), p.S30-S31

2003

Volltextzugriff (PDF)

Mechanical behavior of a highly oriented polyethylene rod

Journal of polymer science. Polymer physics edition, 1977-09, Vol.15 (9), p.1685-1693

1977

Volltextzugriff (PDF)

Dynamic Mechanical Properties of Concentrated Solutions of Sodium Desoxyribonucleate

Journal of physical chemistry (1952), 1956-11, Vol.60 (11), p.1575-1578

1956

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial

Clinical Impact of a Value-Based Decision: A Surgical Case Study

Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on circulating dendritic cells (DC) in patients with surgically resected high risk cutaneous melanoma

Abstract 4224: CD133 knockdown sensitizes melanoma to kinase inhibitors

Abstract 3891: CD133 is associated with resistance of melanoma to multikinase inhibition

Abstract 1097: Immunohistochemical expression of growth factor receptors in different stages of human cutaneous melanoma

Abstract 3349: Immunoexpression of human melanoma stem markers during progressive stages of the disease

Abstract 1921: Nonadherent human melanoma cell lines from lymph node metastases coexpress B cell markers and melanoma antigens

NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer

NSABP B-38: Definitive analysis of a randomized adjuvant trial comparing dose-dense (DD) AC followed by paclitaxel (P) plus gemcitabine (G) with DD AC followed by P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer

Diminished dose minimally invasive radioguided parathyroidectomy : A case for radioguidance. Discussion

In vivo effects of sequential granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-2 (IL-2) on depressed peripheral blood dendritic cell (DC) counts in patients with stage IIB–IV melanoma

The Effect of Sequential Administration of Human Granulocyte-Macrophage Colony Stimulation Factor (GM-CSF) and Interleukin-2 (IL-2): A New Postoperative Adjuvant Therapy in High-Risk Melanoma Patients

Mechanical behavior of a highly oriented polyethylene rod

Dynamic Mechanical Properties of Concentrated Solutions of Sodium Desoxyribonucleate

Aktive Filter

Suchergebnisse filtern